Adriana Pleșa

2.8k total citations
79 papers, 1.1k citations indexed

About

Adriana Pleșa is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Adriana Pleșa has authored 79 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 24 papers in Molecular Biology and 20 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Adriana Pleșa's work include Acute Myeloid Leukemia Research (31 papers), Acute Lymphoblastic Leukemia research (18 papers) and Cervical Cancer and HPV Research (12 papers). Adriana Pleșa is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Acute Lymphoblastic Leukemia research (18 papers) and Cervical Cancer and HPV Research (12 papers). Adriana Pleșa collaborates with scholars based in France, Romania and Slovakia. Adriana Pleșa's co-authors include Charles Dumontet, Gabriela Anton, Anca Botezatu, Isabelle Tigaud, Xavier Thomas, Marielle Chiron, François Vallée, Marie-Cécile Wetzel, Véronique Blanc and Jutta Deckert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Adriana Pleșa

76 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriana Pleșa France 18 487 464 311 184 168 79 1.1k
Marion Baudard France 18 686 1.4× 541 1.2× 369 1.2× 176 1.0× 312 1.9× 34 1.3k
Shinichi Mizuno Japan 16 698 1.4× 1.0k 2.3× 405 1.3× 210 1.1× 316 1.9× 46 1.8k
Anna van Rhenen Netherlands 13 696 1.4× 404 0.9× 408 1.3× 124 0.7× 300 1.8× 39 1.2k
Carolina Schinke United States 21 899 1.8× 692 1.5× 662 2.1× 162 0.9× 215 1.3× 142 1.4k
Benoît Tessoulin France 18 365 0.7× 436 0.9× 516 1.7× 244 1.3× 219 1.3× 79 1.2k
Ugo Consoli Italy 17 257 0.5× 367 0.8× 395 1.3× 181 1.0× 239 1.4× 36 863
Joost W van der Heijden Netherlands 10 317 0.7× 561 1.2× 301 1.0× 101 0.5× 169 1.0× 22 1.1k
Wichai Chinratanalab United States 11 413 0.8× 314 0.7× 512 1.6× 99 0.5× 164 1.0× 48 1.0k
Emanuele Ammatuna Netherlands 19 770 1.6× 850 1.8× 228 0.7× 408 2.2× 206 1.2× 63 1.6k
Charlotte Guldborg Nyvold Denmark 18 529 1.1× 364 0.8× 167 0.5× 185 1.0× 98 0.6× 73 982

Countries citing papers authored by Adriana Pleșa

Since Specialization
Citations

This map shows the geographic impact of Adriana Pleșa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Pleșa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Pleșa more than expected).

Fields of papers citing papers by Adriana Pleșa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Pleșa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Pleșa. The network helps show where Adriana Pleșa may publish in the future.

Co-authorship network of co-authors of Adriana Pleșa

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Pleșa. A scholar is included among the top collaborators of Adriana Pleșa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Pleșa. Adriana Pleșa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gui, Gege, Christophe Roumier, Georgia Andrew, et al.. (2024). Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance. Leukemia. 38(8). 1667–1673. 9 indexed citations
2.
Diaconu, Carmen C., Adriana Pleșa, Ana Iulia Neagu, et al.. (2024). LncRNAs expression profile in a family household cluster of COVID‐19 patients. Journal of Cellular and Molecular Medicine. 28(7). e18226–e18226. 2 indexed citations
3.
Pleșa, Adriana, Gaëlle Fossard, Fiorenza Barraco, et al.. (2022). Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study. Transplantation and Cellular Therapy. 29(1). 38.e1–38.e9. 4 indexed citations
4.
Fournier, Élise, Maël Heiblig, Pascale Flandrin‐Gresta, et al.. (2022). Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group. Leukemia. 36(5). 1390–1400. 2 indexed citations
5.
Simonin, Mathieu, Nathalie Garnier, Ludovic Lhermitte, et al.. (2022). Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia. Modern Pathology. 35(9). 1227–1235. 13 indexed citations
6.
Trinquand, Amélie, Adriana Pleșa, Nathalie Aladjidi, et al.. (2021). Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and NOTCH1/FBXW7 Status. HemaSphere. 5(10). e641–e641. 5 indexed citations
7.
Boyer, Thomas, Adeline Barthélémy, Alice Marceau‐Renaut, et al.. (2019). Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study. Cancers. 11(9). 1323–1323. 29 indexed citations
8.
Pleșa, Adriana, Hélène Labussière‐Wallet, Sandrine Hayette, et al.. (2019). Efficiency of blinatumomab in a t(8;21) acute myeloid leukemia expressing CD19. Haematologica. 104(10). e487–e488. 5 indexed citations
9.
Paubelle, Étienne, Adriana Pleșa, Sandrine Hayette, et al.. (2019). Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1. SHILAP Revista de lepidopterología. 7(2). 121–130. 8 indexed citations
10.
Maillet, Denis, Nathalie Allioli, Julien Péron, et al.. (2019). Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients. European Urology Oncology. 4(4). 609–617. 18 indexed citations
11.
Boyer, Thomas, Adriana Pleșa, Pauline Peyrouze, et al.. (2018). Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up. Journal of Visualized Experiments. 10 indexed citations
12.
Deckert, Jutta, Marie-Cécile Wetzel, Laura M. Bartle, et al.. (2014). SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies. Clinical Cancer Research. 20(17). 4574–4583. 245 indexed citations
13.
Pleșa, Adriana, et al.. (2014). Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients. Archives of Virology. 159(12). 3305–3320. 12 indexed citations
14.
Pleșa, Adriana, Mohamed Elhamri, Gilles Clapisson, et al.. (2014). Higher percentage of CD34 + CD38− cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia. Leukemia & lymphoma. 56(3). 622–629. 9 indexed citations
15.
Hayette, Sandrine, Xavier Thomas, Laurent Jallades, et al.. (2012). High DNA Methyltransferase DNMT3B Levels: A Poor Prognostic Marker in Acute Myeloid Leukemia. PLoS ONE. 7(12). e51527–e51527. 49 indexed citations
16.
Dalle, Stéphane, Lina Reslan, Frank Herting, et al.. (2011). Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101. Molecular Cancer Therapeutics. 10(1). 178–185. 97 indexed citations
17.
Elhamri, Mohamed, Isabelle Tigaud, Youcef Chelghoum, et al.. (2011). Minimally differentiated acute myeloid leukemia (FAB AML-M0): Prognostic factors and treatment effects on survival—A retrospective study of 42 adult cases. Leukemia Research. 35(8). 1027–1031. 3 indexed citations
18.
Dumontet, Charles, Stefano Landi, Tony Reiman, et al.. (2009). Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan. Bone Marrow Transplantation. 45(8). 1316–1324. 36 indexed citations
19.
Chelghoum, Youcef, Adriana Pleșa, Mohamed Elhamri, et al.. (2007). Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia. Cancer. 112(3). 572–580. 38 indexed citations
20.
Păunescu, Virgil, et al.. (2003). Endothelial cells from hematopoietic stem cells are functionally different from those of human umbilical vein. Journal of Cellular and Molecular Medicine. 7(4). 455–460. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026